Cite
HARVARD Citation
Bailly, C. et al. (2022). Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma. Hematological oncology. 40 (4), pp. 796-800. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bailly, C. et al. (2022). Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma. Hematological oncology. 40 (4), pp. 796-800. [Online].